Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells

被引:42
作者
Castellone, MD
Celetti, A
Guarino, V
Cirafici, AM
Basolo, F
Giannini, R
Medico, E
Kruhoffer, M
Orntoft, TF
Curcio, F
Fusco, A
Melillo, RM
Santoro, M
机构
[1] Univ Naples Federico II, Fac Med, Dipartimento Biol & Patol Cellulare & Mol, CNR,Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy
[2] Dipartimento Oncol, Pisa, Italy
[3] Univ Turin, Inst Canc Res & Treatment IRCC, Div Mol Oncol, Candiolo, TO, Italy
[4] Aarhus Univ Hosp, Dept Clin Biochem, Mol Diagnost Lab, DK-8000 Aarhus, Denmark
[5] Univ Udine, Dipartimento Patol & Med Sperimentale & Clin, I-33100 Udine, Italy
关键词
kinase; carcinoma; motility; Ras; tyrosine; thyroid;
D O I
10.1038/sj.onc.1207322
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Papillary thyroid carcinomas are characterized by rearrangements of the RET receptor tyrosine kinase generating RET/ PTC oncogenes. Here we show that osteopontin ( OPN), a secreted glycoprotein, is a major RET/ PTC- induced transcriptional target in PC Cl 3 thyroid follicular cells. OPN upregulation depended on the integrity of the RET/ PTC kinase and tyrosines Y1015 and Y1062, two major RET/ PTC autophosphorylation sites. RET/ PT C also induced a strong overexpression of CD44, a cell surface signalling receptor for OPN. Upregulation of CD44 was dependent on RET/ PTC Y1062, as well. Constitutive OPN overexpression or treatment with exogenous recombinant OPN sharply increased proliferation, Matrigel invasion and spreading in collagen gels of RET/ PTC- transformed PC Cl 3 cells. These effects were impaired by the treatment of PC Cl 3- RET/ PTC cells with OPN- and CD44- blocking antibodies. Thus, RET/ PTC signalling triggers an autocrine loop involving OPN and CD44 that sustains proliferation and invasion of transfomed PC Cl 3 thyrocytes.
引用
收藏
页码:2188 / 2196
页数:9
相关论文
共 39 条
[1]   Protein kinase Cα activation by RET:: evidence for a negative feedback mechanism controlling RET tyrosine kinase [J].
Andreozzi, F ;
Melillo, RM ;
Carlomagno, F ;
Oriente, F ;
Miele, C ;
Fiory, F ;
Santopietro, S ;
Castellone, MD ;
Beguinot, F ;
Santoro, M ;
Formisano, P .
ONCOGENE, 2003, 22 (19) :2942-2949
[2]   A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with Shc adaptor proteins [J].
Asai, N ;
Murakami, H ;
Iwashita, T ;
Takahashi, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) :17644-17649
[3]   Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity [J].
Ashkar, S ;
Weber, GF ;
Panoutsakopoulou, V ;
Sanchirico, ME ;
Jansson, M ;
Zawaideh, S ;
Rittling, SR ;
Denhardt, DT ;
Glimcher, MJ ;
Cantor, H .
SCIENCE, 2000, 287 (5454) :860-864
[4]   Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions [J].
Bartolazzi, A ;
Gasbarri, A ;
Papotti, M ;
Bussolati, G ;
Lucante, T ;
Khan, A ;
Inohara, H ;
Marandino, F ;
Orlandi, F ;
Nardi, F ;
Vecchione, A ;
Tecce, R ;
Larsson, O .
LANCET, 2001, 357 (9269) :1644-1650
[5]   Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangement [J].
Basolo, F ;
Giannini, R ;
Toniolo, A ;
Casalone, R ;
Nikiforova, M ;
Pacini, F ;
Elisei, R ;
Miccoli, P ;
Berti, P ;
Faviana, P ;
Fiore, L ;
Monaco, C ;
Pierantoni, GM ;
Fedele, M ;
Nikiforov, YE ;
Santoro, M ;
Fusco, A .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (05) :608-614
[6]  
Borrello MG, 1996, MOL CELL BIOL, V16, P2151
[7]   The roles of phosphotyrosines-294,-404, and-451 in RET/PTC1-induced thyroid tumor formation [J].
Buckwalter, TLF ;
Venkateswaran, A ;
Lavender, M ;
La Perle, KMD ;
Cho, JY ;
Robinson, ML ;
Jhiang, SM .
ONCOGENE, 2002, 21 (53) :8166-8172
[8]  
Carlomagno F, 2002, CANCER RES, V62, P7284
[9]   Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes [J].
Castellone, MD ;
Cirafici, AM ;
De Vita, G ;
De Falco, V ;
Malorni, L ;
Tallini, G ;
Fagin, JA ;
Fusco, A ;
Melillo, RM ;
Santoro, M .
ONCOGENE, 2003, 22 (02) :246-255
[10]   The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease [J].
Chabas, D ;
Baranzini, SE ;
Mitchell, D ;
Bernard, CCA ;
Rittling, SR ;
Denhardt, DT ;
Sobel, RA ;
Lock, C ;
Karpuj, M ;
Pedotti, R ;
Heller, R ;
Oksenberg, JR ;
Steinman, L .
SCIENCE, 2001, 294 (5547) :1731-1735